Tyler Philip Cox

Directed growth and management of southeast/east coast market. Oversaw transition from early commercialization and LMR to scaled IDN adoption across east coast. Led multiple successful platform launches in imaging and physiology, culminating in acquisition by Philips Corporation. Supervised teams of representatives and clinical specialists throughout east coast.

• Formulated and implemented regional sales strategy to enhance market share.
• Major Contributor in Philips Acquisition
• 150% to annual quota
• 125% Quota Q4
• Executed VBA with Centennial Medical Center resulting in removal of Abbott
• Cultivated a center of excellence focused on driving innovation and operational efficiency.
• Developed TriStar Centennial into the highest volume account nationally
• Obtained over 65% of Centennials imaging marketshare
• Grew region from $0 to 1M+ with forecast 2.5x in FY 26
• HCA Standardization underway early Q1 FY 26
• Lead launches to optimize teams bandwidth
• Closed University of Miami and obtained capital purchase
• Hired rep in Tampa
• Hired Rep in Ohio
• Hired two Clinicals in Atlanta

Sales of Atherectomy and Thrombectomy devices, PTA and drug coated balloons, Venous, Bare Metal and Covered Stents, Grafts, Sheaths, and Structural heart balloons to Interventional Cardiologists, Radiologists, Vascular Surgeons, C-Suites and Value Analysis Committees. Tasked with hiring two clinicals and one associate rep to help support and grow state of Georgia.

• Achieved 102% of quota
• Generated $500K in total territory growth
• Improved territory ranking from #77 to # 24 in one year (out of 80)
• Established one Regional Key Opinion Leader
• Converted four major competitive accounts

Promoted to help manage five sales reps and three clinical specialists in sales of Ultrasound Imaging, Contrast Injection systems, and FFR platforms to Cath lab, IR, OR, Neuro, ER, C-Suites and Value Analysis Committees. Negotiate GPO contracts at the local and national levels while assisting in IDN and GPO negotiations in the Southeast.

• Region achieved average annual quota of 106%
• Personally achieved 206% of quota
• Opened over 11 major new accounts
• Established one National Key Opinion Leader
• Generated over $4M in total revenues
• Ranked #1 in National Sales Force
• Achieved $2.2M in total growth
• A provider of contrast injector, FFR, & IVUS catheter diagnostic technologies

Selling Capital Intravascular Ultrasound Imaging consoles, Contrast injection Imaging system, and Physiology portfolio to hospitals, ASCs, and OBLS. Work with Cath lab, IR, OR, Neuro, ER, C-Suites and Value Analysis Committees

• Generated over $2M of total growth in Georgia territory since 2019
• Achieved average annual quota of 154% across all products
• Ranked #1 in National Sales Force in 2022 ( out of 48)
• Consistently ranked in top ten of National Sales Force
• Achieved $2.4M in total growth
• Finished 193% to IVUS quota FY 21.
• Finished 160% to angiography quota FY 22.
• Finished 195% to Imaging Quota FY 22.
• Finished 310% to Capital Quota FY 22.

• President’s Club Winner in 2018
• Ranked #1 in National Sales Force
• Achieved 110% to quota FY 18

• Sold diabetes products into hospitals and endocrinologists. Utilized distribution relationships to grow southeast territory.
• Ranked #1 in National Sales Force
• Achieved 140% to quota